Novel, disposable, self-inserted, vaginal device for the non-surgical management of pelvic organ prolapse: efficacy, safety, and quality of life - BMC Women's Health - BioMed Central

2 years ago 29

BMC Women's Health volume 22, Article number: 459 (2022) Cite this article

Abstract

Background

We evaluated a caller disposable, collapsible, ring-shaped vaginal instrumentality that is self-inserted wrong an applicator and removed with a string. The instrumentality was developed to flooded the drawbacks of existing ringing pessaries for non-surgical pelvic organ prolapse absorption (POP).

Methods

The superior nonsubjective efficacy endpoint of this prospective, interventional, multicenter, self-controlled, and home-use survey was the proportionality of subjects with improved staging connected the Pelvic Organ Prolapse Quantification (POP-Q) scale. Subjective efficacy was assessed utilizing the POP symptoms alleviation score. Safety was evaluated by signaling the complaint and incidence of adverse events (AEs) successful a regular diary, and prime of beingness (QoL) was evaluated utilizing the modified Pelvic Floor Impact (PFIQ-7) and Pelvic Floor Disability Index (PFDI-20) questionnaires.

Results

A full of 94 usage cycles were observed successful a radical of 52 participants (mean property 60.2 ± 10.5 years, 81.1% postmenopausal) who utilized the instrumentality for 3558 days. Of these, 24 participants completed 1 usage cycle, 14 completed 2 usage cycles, and 14 completed 3 usage cycles with 28–45 days of ProVate usage successful each usage cycle. All patients experienced greater than 2 POP-Q signifier reductions. The descent was wholly reduced to POP-Q signifier 0 successful 97.8% of participants. The POP grounds alleviation questionnaire showed important subjective efficacy (P < 0.0001). The modified PFDI-20 and PFIQ-7 scores besides improved substantially (P < 0.0001 for both). There were 91 nonserious device-related AEs: 98.9% were mild and 87.9% anticipated, with nary vaginal infection, and 1 lawsuit of urinary tract infection.

Conclusion

The caller instrumentality substantially reduces prolapse and provides important subjective POP grounds alleviation and QoL improvement, with minimal AEs. The instrumentality whitethorn alteration women to self-manage their prolapse with a small, disposable instrumentality that minimizes self-touching and predominant dependency connected the clinic.

Trial registration

Clinical.Trials.gov, NCT02239133, posted September 12, 2014 (retrospectively registered).

Peer Review reports

Background

Although insignificant degrees of pelvic organ prolapse (POP) impact up to 75% of women who person delivered vaginally [1], symptomatic POP affects 3–8% of the pistillate colonisation [2,3,4]. Approximately 3.5 cardinal women successful the United States question aesculapian assistance for symptomatic POP [5], with 210,000–300,000 undergoing surgical treatments per twelvemonth and the remainder being managed with vaginal pessaries, chiefly ring-shaped, oregon remaining untreated. Although information connected the proportionality of pessary users is scarce, a 1:1 ratio of pessary users to women with untreated POP tin beryllium assumed [6]. Pessaries person been utilized successful the non-surgical absorption of POP for decades; they are considered effectual and safe. However, existing pessaries person important drawbacks, which bounds their wide usage [7]. Moreover, they are associated with a precocious complaint of discontinuation, which exceeds 50% wrong 12 months [8], with the large reasons being nonaccomplishment to clasp the pessary and inability to insert and region the instrumentality by the user, tendency for different attraction modality (e.g., surgery), adverse events (AEs), and intersexual disturbances. Existing ringing pessaries are reusable lone [9] and are ample and intrusive, with diameters ranging from 54 to 110 mm. They are partially squeezed (reduced dimensions) during insertion but afloat opened during removal, resulting successful the astir communal AE-discomfort and symptom erstwhile pressing and widening the introitus.

We assumed that much women than antecedently believed necessitate oregon privation non-surgical POP management, and that vaginal pessaries whitethorn beryllium a viable enactment for them. However, they are hesitant to usage them owed to aggregate difficulties, conscionable arsenic galore healthcare providers (HCPs) are hesitant to urge a attraction with truthful galore complications [10]. The immense spread betwixt existing cumbersome pessary absorption and women’s tendency for a much pleasant, self-manageable, and comfy POP control, including unhindered intercourse, necessitated the improvement of a caller instrumentality that combined the benefits of a ringing pessary with important reductions in, oregon elimination of, its large drawbacks. To make a caller attraction option, we conducted a lit hunt and HCPs surveys for knowing the astir bothersome complaints related to existing ringing pessaries and designed mitigation options to flooded each ailment (Table 1). Following this, we developed the ProVate device, which has a slender (28 mm) body, that transforms into a ringing pessary with six sizes (61–91 mm) and is intuitively self-inserted/removed, akin to however a menstrual tampon is inserted and removed.

Table 1 Identified downsides of existing ringing pessaries and imaginable mitigations

ProVate (Fig. 1) is simply a small, disposable, flexible, and self-expanding vaginal ringing pessary that comes acceptable for usage wrong an applicator and with casual removal aft a illness by pulling a string. Like existing rigid ringing pessaries, ProVate was designed to relation arsenic a scaffold that lifts the prolapsed vaginal walls erstwhile successful place. Expectedly, erstwhile pessaries of adjacent size are used, their intravaginal mechanical relation should beryllium equivalent. Furthermore, their nonsubjective and subjective efficacies and interaction connected the prime of beingness (QoL) are expected to beryllium similar. However, with ProVate, less AEs arsenic good arsenic enhanced idiosyncratic acquisition and restitution are expected, allowing women to self-manage POP and their intimate behaviour [11].

Fig. 1
figure 1

The ProVate Device with its assorted shapes during insertion and removal. The ProVate instrumentality is provided cleanable and individually wrapped. It is disposable for contiguous vaginal insertion utilizing a disposable applicator (a). During vaginal insertion, which is akin to inserting a menstrual tampon, the plunger is pushed, and the slender compacted instrumentality wrong the applicator gradually enlarges to go a ringing (b). After afloat pushing the plunger, the ringing becomes afloat deployed (c). The applicator past separates from the ringing and is removed from the vagina for disposal, leaving the drawstring disposable for aboriginal removal (d). The deployed ringing whitethorn stay successful the vagina for up to 7 days (e). A propulsion connected the drawstring collapses the ringing into is its slender pre-insertion size for comfy removal and disposal (fh). (Source: ConTIPI Medical Ltd., with permission)

The plan of a prospective longitudinal location proceedings to measure nonsubjective and subjective efficacies, safety, QoL, and users’ restitution was driven by the comparable functionality of ProVate and a ringing pessary. The pursuing were the trial’s circumstantial characteristics:

  • A single-arm proceedings successful which each idiosyncratic served arsenic her ain power (demonstrating quantifiable POP comparisons earlier and during utilizing the instrumentality done well-established show indicators, specified arsenic the Pelvic Organ Prolapse (POP-Q) quantification standard [12] and validated QoL questionnaires [13]).

  • A longitudinal, hypothesis-driven, and statistically powered survey wherever immoderate participants utilized the instrumentality for much than 1 ~45-day usage rhythm (e.g. 2–3 usage cycles). This allowed information postulation from 94 usage cycles of ~45 days each and from users who repeatedly utilized the instrumentality during 2 & 3 consecutive usage periods for implicit 2 years. This plan facilitated follow-up of users during longer periods, implicit agelong clip span, with a larger fig of evaluable participants (94 usage cycles successful 52 partcipants).

The survey assumed that though usage was moved into the homes and hands of laymen, the device’s efficacy (prolapse signifier and related symptoms) successful reducing POP would stay high. It was besides anticipated that AEs would stay debased aft insertion and removal successful tiny dimensions of an easy-to-use disposable instrumentality for a abbreviated play of time. Women tin regenerate the instrumentality arsenic often arsenic they wish, with limitations of up to 7 days per device, to guarantee the debased complaint of AEs, arsenic this complies with the guidelines of the Society of Obstetricians and Gynecologists of Canada for women who tin comply with pessary self-care [14].

Methods

This probe was a prospective, interventional, multicenter, one-arm, open-label, self-controlled, home-use study. The study’s nonsubjective was to corroborate the efficacy and information of the ProVate instrumentality for regular use. The survey was performed pursuing the ethical standards successful the Declaration of Helsinki. Furthermore, the institution’s morals committee approved the probe (Assuta-Maccabi Helsinki committee, app #2014038), aft which each subordinate provided written informed consent.

The survey was conducted successful 3 outpatient gynecology/urogynecology clinics successful Israel betwixt August 2014 and June 2016. Symptomatic participants were recruited from the clinics’ database oregon pursuing advertisements.

Figure 2 presents the survey travel and instrumentality usage. After screening (visit 1), eligible participants were fitted with the close size (visit 2) and underwent grooming connected instrumentality use. Size confirmation was conducted astatine the survey session pursuing 2–3 days of location usage (visit 3). Then, the taxable was refitted if the size was either excessively tiny (causing expulsion) oregon excessively ample (discomforting). During the usage period, participants were instructed to usage arsenic galore devices arsenic they wished for 1 to 7 days each, and to capable successful a regular diary, documenting each device’s magnitude of use, functionality, and AEs. The home-use information of the survey (termed the usage period oregon usage cycle) began aft sojourn 3 and lasted up to 45 days. Participants were instructed to usage ProVate for astatine slightest 28 days wrong the 45 days. An ultrasound scan was conducted to estimation the post-void residual (PVR) urine earlier and portion utilizing ProVate. Participants were examined vaginally during each session sojourn by the aforesaid gynecologist/urogynecologist to measure the signifier of prolapse (POP-Q scale) with oregon without the instrumentality and look for signs of infection, bleeding, and vaginal partition trauma.

Fig. 2
figure 2

Flow diagram of methodology comparing POP- Q results from the extremity of sojourn 5 with those of baseline

Similar ProVate models were tested successful an iterative, consecutive fashion, including the last marketed version. Changes betwixt instrumentality models were constricted to the applicator, whereas the existent ProVate ring, which affects efficacy and safety, remained the same.

Inclusion criteria included women aged 21–80 years with symptomatic sensation of vaginal prolapse, diagnosed with POP-Q signifier 2–4 prolapse successful 1 oregon much sites on the vaginal walls, quality to usage some hands and insert a instrumentality into the vagina, and the quality to clasp a 61- to 91-mm pessary. Exclusion criteria included erstwhile inability to accommodate tampons oregon vaginal pessaries; existent information successful different objective study; comorbid condition(s) oregon terrible systemic diseases that could bounds the subject’s quality to enactment successful the study; pregnancy, suspected pregnancy, oregon volition to go large during the study; abnormal vaginal bleeding successful the erstwhile 6 months; erstwhile vaginal country during the preceding 3 months; severely atrophic vagina; existing vaginal oregon vulvar laceration; symptomatic vaginal oregon urinary tract infection, arsenic determined by carnal introspection and laboratory results; recurrent urinary tract infections; and abnormal cervical cytology.

The superior endpoint of this survey was the proportionality of participants who showed an betterment of astatine slightest 1 signifier from baseline connected the POP-Q standard connected the 5th sojourn portion utilizing ProVate, arsenic evaluated by per-protocol (PP) analysis. The investigation tested the null proposal that the proportionality of participants with an betterment from baseline was <70%. The alternate proposal was that the proportionality of participants with an betterment was ≥70%. The null proposal was tested utilizing the nonstop binomial test. The secondary nonsubjective efficacy endpoint was the proportionality of participants who were yet evaluated arsenic POP-Q signifier 0 oregon 1 prolapse connected the last visit. The secondary subjective endpoints included the betterment of POP symptoms (assessed by an author-compiled POP symptoms alleviation questionnaire), betterment successful QoL (assessed utilizing the modified PFDI-20 and modified PFIQ-7 questionnaires), and subordinate restitution with the instrumentality (evaluated by an author-compiled questionnaire).

Objective efficacy, oregon betterment successful the prolapsed stage, was evaluated astatine each survey visits utilizing the POP-Q scale. Additionally, subjective efficacy was assessed utilizing the POP symptoms alleviation score, which was developed and compiled by the authors to measure the alteration successful POP-related complaints earlier and during treatment. Ten circumstantial POP-related complaints were graded connected a standard ranging from 0 to 4 (0 = no ailment astatine all to 4 = significant complaint), and scores from sojourn 1 (before utilizing the ProVate) and sojourn 5 (while utilizing the ProVate) were normalized to the 0–100 scale, analyzed, and compared.

Changes successful QoL were assessed utilizing the applicable parts of the validated PFDI-20 and PFIQ-7 QoL questionnaires (i.e., lone those questions that are pertinent to POP). In the modified PFIQ-20 score, 10 of the 20 questions successful the archetypal questionnaire were utilized to measure the load of pelvic level disorders owed to circumstantial inabilities. Possible scores scope from 0 to 4, wherever 0 = not astatine all and 4 = very much. In the modified PFIQ-7 questionnaire, which quantifies the load of assorted pelvic level disorders connected the quality to execute definite regular activities, lone the 7 questions related to the vagina oregon pelvis were incorporated, with imaginable scores ranging from 0 to 3, wherever 0 = not astatine all and 3 = very much. Results were normalized to a standard of 0–100.

Participants were questioned regarding their restitution portion utilizing the instrumentality during the 3 circumstantial usage steps: insertion, usage, and removal. At the extremity of the survey (visit 5), complaints peculiar to the usage of the ProVate, with accent connected the quality to insert and region the instrumentality (to exclude manus question limitation), were recorded successful an author-compiled questionnaire. Participants’ responses were recorded connected a standard ranging from 0 to 4, wherever 0 means nary complaints (not having immoderate complaints astatine all) and 4 means a precocious level of complaints. Results were past analyzed and plotted connected a standard of 0–100, wherever 0 indicates total dissatisfaction from instrumentality usage and 100 means complete satisfaction. McNemar’s tests were utilized to measure the proportionality of participants who scored circumstantial questions arsenic having nary ailment astatine all (0), earlier and portion utilizing the device, for each point separately.

Safety was assessed by signaling the complaint and incidence of anticipated AEs, including vaginal partition trauma (e.g., erosions, abrasions, ulcerations), vaginal/urine infections, pain, spotting, discomfort, de novo oregon worsening urinary incontinence and constipation, complaint and incidence of superior AEs, and complaint and incidence of each AEs (anticipated and non-anticipated, superior and nonserious, related and unrelated to the survey device). AEs were assessed utilizing 1 of the pursuing methods: regular diary, scheduled gathering with the investigator, nonscheduled telephone from the subject, and scheduled play telephone telephone to the subject.

The afloat investigation (FA) acceptable included each eligible participants who utilized astatine slightest 1 instrumentality (even if the insertion process was ne'er completed). The FA acceptable served arsenic the main investigation acceptable for the information assessment. The PP investigation acceptable included each participants from the FA acceptable who utilized the survey instrumentality models for astatine slightest 20 days, with nary important protocol deviation. The PP investigation acceptable served arsenic the main investigation acceptable for the analyses of the superior and secondary endpoints.

Statistical analyses were performed utilizing SAS v9.4 (SAS®, SAS Institute Cary, NC USA) software. Under the assumptions (100% success), the illustration size required to trial the null proposal astatine a 5% value level and with 80% powerfulness was astatine slightest 36 evaluable participants.

Results

The participants’ mean property was 60.2 ± 10.5 years, and 52.3% were betwixt 61 and 70 years of age; their mean assemblage wide scale was 25.48 ± 4.16 kg/m2. Of the 151 births reported, 108 were spontaneous vaginal deliveries, 39 were vaginal and required instrumentation, and 4 required cesarean delivery. The mean value of the newborns was 3662 ± 449 g. Most participants (81.1%) were postmenopausal, with a mean magnitude of amenorrhea of 14.2 years. Moreover, 13 participants utilized systemic hormone replacement therapy, and 6 utilized vaginal estrogen cream.

Altogether, 94 usage cycles successful 3 clinics were recorded. This probe was a longitudinal survey conducted implicit 2 years with 3 phases (each signifier >6 months apart) that tested somewhat antithetic applicators of the instrumentality (Fig. 3). No changes to the existent ProVate ringing were made. Phase A included 33 participants (usage cycles), of whom 20 were besides successful signifier B. Additional participants were recruited for signifier C, which was completed by 41 participants utilizing the last applicator (of these, 22 participants already utilized the instrumentality astatine signifier A/B). Altogether, 52 symptomatic women completed this study; of these, 24 completed 1 usage cycle, 14 completed 2 usage cycles, and 14 completed 3 usage cycles with 28–45 days of ProVate usage successful each usage cycle. Participants who utilized much than 1 exemplary were reconfirmed for inclusion and exclusion criteria earlier the adjacent usage cycle, which was frankincense considered arsenic an further usage rhythm (altogether: 94).

Fig. 3
figure 3

The 3 phases of the study. Altogether, 94 usage cycles successful 3 clinics were recorded implicit 2 years with 3 phases (each signifier >6 months apart) Phase A included 33 participants (usage cycles) who completed the survey PP, of whom 20 besides tested ProVate successful signifier B. Additional participants were recruited for signifier C, which was completed PP by 41 participants of which 22 utilized the instrumentality during phases A/B. Altogether, 94 usage cycles were completed by 52 symptomatic women, of whom 24 completed 1 usage cycle, 14 completed 2 usage cycles, and 14 completed 3 usage cycles. Participants who utilized much than 1 exemplary were reconfirmed for inclusion and exclusion criteria earlier the adjacent usage cycle, which was frankincense considered arsenic an further usage cycle

Eighty-seven caller participants were screened, of whom 18 were archetypal surface failures. Additionally, during the study, 8/69 could not beryllium fitted with disposable sizes (e.g., wide introitus oregon abbreviated vagina), 3/69 discontinued information due to the fact that of AEs, 2/69 were withdrawn due to the fact that of their inability to insert the instrumentality by themselves (short hands and inability to crook back), 1/69 opted for surgery, and 3/69 were removed owed to violations of survey procedures.

In total, aft instrumentality sizing and accommodation, during the instrumentality usage play only, 992 ProVate devices were utilized implicit 3393 usage days successful the PP population, with an mean of 36.1 ± 5.70 days per subject, and 1592 devices were utilized implicit 3558 survey days successful the FA (safety) group.

Objective efficacy: Reduction of POP stage

The survey colonisation included participants with aggregate prolapse sites (e.g., anterior and apical). While utilizing the ProVate device, the POP simplification was not constricted to a circumstantial location. Still, upward distension of the vaginal apex resulted successful a flattening and diminution of the prolapse astatine different vaginal sites. General efficacy analyses were conducted connected the PP acceptable utilizing 94 usage cycles. However, successful 2 cases, the POP-Q results aft the survey were missing. Hence, the simplification successful POP was calculated implicit lone 92 cases.

In the PP set, the pre-study POP-Q staging included 28 usage cycles (29.79%) with signifier 2 prolapse and 66 (70.21%) usage cycles with signifier 3 prolapse (Fig. 4), each symptomatic. In each usage cycles (100%), a simplification of astatine slightest 2 POP-Q stages portion utilizing the ProVate instrumentality (95% nonstop assurance interval [CI] [96.07; 100]) was observed (Table 2). Besides, successful 64 of 66 (97%) cases with POP-Q signifier 3 prolapse, a simplification of 3 POP-Q stages (95% nonstop CI [89.48; 99.63]) was observed. Therefore, it is evident that the archetypal nonsubjective efficacy endpoint was met, and the null proposal was rejected (P < 0.001).

Fig. 4
figure 4

Comparison of nonsubjective efficacy (POP-Q staging) earlier and portion utilizing the ProVate Device. Before utilizing ProVate, 70.21% of users had POP-Q signifier 3 prolapse, whereas 29.79% had signifier 2 prolapse. While utilizing ProVate, 100% of subjects had a important simplification of prolapse to POP-Q signifier 0/1. (POP-Q = Pelvic Organ Prolapse Quantification)

Table 2 Prolapse simplification portion utilizing the ProVate Device (POP-Q staging, 94 usage cycles, PP set, POP = Pelvic Organ Prolapse, POP-Q = Pelvic Organ Prolapse Quantification)

A secondary nonsubjective efficacy endpoint relates to the proportionality of participants who yet had either POP-Q signifier 0 oregon 1 prolapse astatine the extremity sojourn portion utilizing ProVate. There was nary prolapse (POP-Q signifier 0) successful 90 usage cycles (97.8%), whereas determination was POP-Q signifier 1 prolapse successful 2 usage cycles (2.2%; Table 2). Collectively, successful 92 of 92 cases (100%), prolapse was reduced to either signifier 0 oregon 1 (P < 0.0001).

This betterment was demonstrated astatine each 3 survey clinics with nary statistically important quality among sites; hence, information from each survey sites were pooled.

Subjective efficacy: Reduction of POP symptoms

Figure 5 shows results from the author-compiled POP symptoms alleviation scores obtained from sojourn 1 (before instrumentality use) and sojourn 5 (end visit). The scores were substantially reduced for each of the 10 items, and the mean full people decreased importantly from 29 to 2.7 (P < 0.0001).

Fig. 5
figure 5

Comparison of complaints earlier utilizing ProVate and portion utilizing ProVate. Complaints were graded 0–4 utilizing the POP alleviation people (0 being “no ailment astatine all” and 4 being “significant complaint”). Scores connected sojourn 1 (before utilizing the device) and sojourn 5 (while utilizing the device) were normalized to the 0–100 standard and were analyzed and compared (94 usage cycles, 992 devices, 3393 usage days, PP population; mean full people p < 0.0001, POP = Pelvic Organ Prolapse). (Source: ConTIPI Medical Ltd., with permission)

QoL questionnaires

A statistically important alteration successful each items (implying an betterment successful QoL regarding POP) was observed connected some the modified PFDI-20 and PFIQ-7 QoL questionnaires. Figure 6 shows a important alteration successful each items of the modified PFDI-20 scores. The mean full people decreased from 33.6 earlier utilizing ProVate to 5.1 portion utilizing ProVate (P < 0.0001). The proportionality of participants who scored “not astatine all” for circumstantial items ranged from 5.3 to 76.6% astatine baseline. Subsequently, this worth accrued (80.6 to 98.9%) astatine the survey extremity (P < 0.0001). Figure 7 demonstrates a important alteration successful each modified PFIQ-7 items scores. The mean full people decreased from 24.9 earlier utilizing ProVate to 0.7 portion utilizing ProVate (P < 0.0001). The proportionality of participants who scored “not astatine all” for circumstantial items ranged from 33.0 to 81.9% astatine baseline. However, these values accrued to 95.7% astatine the survey extremity (P < 0.0001).

Fig. 6
figure 6

Modified PFDI-20 Quality of beingness questionnaire. Comparison of POP-relevant questions earlier utilizing ProVate and portion utilizing ProVate. Complaints were graded 0–4 (0 being “no ailment astatine all” and 4 being “significant complaint”). Scores connected sojourn 1 (before utilizing the device) and sojourn 5 (while utilizing the device) were normalized to the 0–100 standard and were analyzed and compared (94 usage cycles, 992 devices, 3393 usage days, PP population; mean full people p < 0.0001, POP = Pelvic Organ Prolapse, PFDI-20 = Pelvic Floor Disability Index 20)

Fig. 7
figure 7

Modified PFIQ-7 Quality of beingness questionnaire. Comparison of POP-relevant questions earlier utilizing ProVate and portion utilizing ProVate. Responses were graded 0–3 (0 being “no ailment astatine all” and 3 being “significant complaint”). Scores connected sojourn 1 (before utilizing the device) and sojourn 5 (while utilizing the device) were normalized to the 0–100 standard and were analyzed and compared (94 usage cycles, 992 devices, 3393 usage days, PP population; mean full people p < 0.0001, POP = Pelvic Organ Prolapse, PFIQ-7 = Pelvic Floor Impact Questionnaire, abbreviated signifier 7)

Subject’s restitution score

As shown successful Fig. 8, the responses to the restitution questionnaire were highly favorable. This fig shows lone the results with scores of “not having immoderate complaints astatine all” fixed for each 14 items, ranging from 77.7 to 100%. Most items scored astatine slightest 90%.

Fig. 8
figure 8

ProVate Satisfaction Score. Chart shows lone responses of “no complaints astatine all” by survey end. Responses were graded 0–4 (0 being “no ailment astatine all” and 4 being “significant complaint”), normalized to the 0–100 scale, analyzed, and compared (94 usage cycles, 992 devices, 3393 usage days, PP population)

AEs

General information analyses were conducted connected the FA set; 98.9% of AEs were mild, and 87.9% were anticipated. There were nary device-related superior AEs, and each AEs resolved wholly with nary sequelae. In each 3 survey parts, portion 124 AEs were reported successful the FA set, 109 AEs were observed successful the PP set. The astir communal AEs were discomfort and spotting, anticipated for each devices utilized vaginally during archetypal usage stages.

Table 3 shows the organisation of device-related AEs wrong the FA and PP sets. In the FA set, 91 AEs occurred successful 51 participants (45.95% of the FA set) portion utilizing 1592 devices implicit 3558 usage days. However, successful the PP set, 77 AEs occurred successful 44 participants (46.81% of the PP set) portion utilizing 992 devices implicit 3393 usage days.

Table 3 Summary of device-related adverse events (AEs) portion utilizing ProVate

Seven cases of vaginal partition trauma (accounting for 7.6% of device-related AEs) were seen astatine the opening of the survey successful lone 4 (3.6%, FA set) participants.

The largest proportionality of AEs consisted of sporadic AEs, usually 1 to 2 complaints each. In the 91 perchance device-related AEs (FA set), 33 (36.3%) were reported during sizing and 58 (63.7%) during the instrumentality usage phase. Most of the device-related AEs occurred wrong 1 week from the survey commencement (58.9%) and during the usage of the archetypal 5 devices (75.8%). This uncovering shows a emblematic learning curve for the caller product.

Specific information points: Vaginal infections, urinary tract infection, and urine retention

There were nary signs oregon symptoms of vaginal infections (based connected self-report oregon vaginal examination). However, 1 lawsuit of urinary tract corruption (UTI) was observed, which was treated with antibiotics. A lawsuit of presumptive UTI was besides observed, successful which the doc commenced treatments without a laboratory trial and without reporting to the site.

PVR urine measurement was studied by ultrasound scan earlier insertion of the archetypal instrumentality and with the instrumentality deployed wrong the vagina (visit 4). There was nary important quality successful PVR betwixt earlier (15.0 ± 15.56 mL [range, 0–53.5 mL]) and portion utilizing the ProVate (14.1 ± 21.9 mL [range, 0–90.7 mL]).

Discussion

While offering caller aspects of location self-insertion and removal of a disposable device, this survey aimed to show the important nonsubjective and subjective efficacy and information of ProVate, unneurotic with the reported summation successful QoL and users’ satisfaction.

The superior nonsubjective efficacy endpoint of the study, the proportionality of participants with astatine slightest a one-stage simplification successful the POP-Q stage, was met and shown to beryllium 100%. In >96%, 2 oregon much stages connected POP-Q were reduced. In >97%, prolapse was reduced to signifier 0, careless of the archetypal stage. The author-compiled POP symptoms alleviation people showed important betterment successful prolapse symptoms portion utilizing the device, reflecting important subjective efficacy, careless of the nonsubjective efficacy.

The prolapse simplification from utilizing ringing pessaries was associated with accrued QoL [15]. In this study, the participants’ QoL improved considerably with ProVate. This uncovering was reflected successful the results from the modified PFIQ-7 and PFDI-20. Furthermore, arsenic indicated by the circumstantial questionnaire, the users’ restitution was significant.

Medical lit cites conflicting information connected the prevalence of AEs wrong groups of pessary users. For example, though Hanson et al. [16] reported that lone 14.5% of users had immoderate complaints, Bai et al. [17] reported that 73.1% experienced AEs, and Sarma et al. [18] reported that 56% had AEs. This ample variability reflects a quality successful reporting. Here an ongoing daily/weekly follow-up of complaints, unneurotic with a regular diary, volition apt pb to a overmuch larger proportionality of complaints. However, the complaint of AEs was inactive comparatively debased with ProVate, and astir AEs were minor, mild, and anticipated.

Most anticipated AEs wrong the survey occurred during the sizing signifier and astatine the archetypal week of the usage phase. These issues diminished erstwhile participants became much experienced with the usage of the instrumentality (“learning curve effect”). Discomfort and spotting travel the archetypal usage of immoderate intravaginal device, including menstrual tampons, chiefly successful those with estrogen deprivation [19]. As anticipated, these 2 were the astir prevalent AEs upon the archetypal usage of ProVate. However, their incidence was debased and diminished with usage experience.

Vaginal partition trauma, an anticipated AE, occurs successful 3–24% of pessary users [20]. In this study, the debased complaint of vaginal partition trauma (3.6%) is attributable to the user’s inexperience and archetypal trials of inserting the device. This mechanics of partition trauma is astir apt antithetic from wherever trauma is caused by prolonged unit [21] (“pressure ulcers”) by a reusable pessary.

Vaginal purulent discharge, itching, and foul odor are communal among pessary users [22, 23], specifically among those who usage them for agelong periods, possibly owed to biofilm enactment [24]. However, nary complaints, objective signs, oregon symptoms of vaginal corruption arose successful this survey portion utilizing ProVate. This uncovering is attributed to the predominant replacement of a caller and cleanable device.

Compared with astir different studies that trust connected representation callback only, a spot of this survey is the regular postulation of AEs successful a diary of much than 3558 usage days. Additional strengths see the agelong usage play (3558 usage days) nether strict supervision and the plan of the survey whereby a strict diligent follow-up was used, which allowed for the aboriginal detection of circumstantial AEs (e.g., vaginal partition trauma) and corrective actions (e.g., instructing participants however to decently insert the device). Another spot of the survey is its longitudinal plan conducted implicit 2 years, enabling capable follow-up connected imaginable precocious AEs and imaginable prolonged usage habits.

A regulation of this survey is its single-arm design, with information collected during usage of the ProVate instrumentality only. However, it should beryllium noted that established and validated cardinal show indicators (POP-Q, PFDI-20, PFIQ-7) were utilized for the main comparisons to analyse functionality, performance, and usability, and that a examination with existing ringing pessaries was not indispensable to found required information and frankincense was not included successful the existent study. Therefore, a aboriginal survey comparing results betwixt ProVate and existing ringing pessaries is needed. Another regulation is the alternatively abbreviated follow-up duration of up to 45 usage days wrong each usage cycle; however, this is undoubtedly capable to show the efficacy and information of a caller device. Simultaneously, participants who repeated usage wrong up to 3 usage cycles successful 2 years really demonstrated prolonged usage habits.

Conclusion

In an epoch wherever galore women debar session visits (e.g., during a pandemic) and erstwhile avoidance of attraction tin pb to complications, ProVate is an illustration of a elemental and disposable self-use location absorption method. This caller absorption modality for POP whitethorn elevate compliance with POP attraction among untreated patients. However, further studies are needed to larn much astir different characteristics of this device.

Availability of information and materials

The information that enactment the findings of this survey are confidential assets of ConTIPI Medical Ltd. Restrictions use to the availability of these data, arsenic they are the company’s confidential and restricted information and are truthful not publically available. However, information whitethorn beryllium disposable from the corresponding writer upon tenable petition and with support of ConTIPI Medical Ltd.

Abbreviations

AE:

Adverse Event

FA:

Full analysis

HCP:

Healthcare providers

PFDI:

Pelvic Floor Disability Index

PFIQ:

Pelvic Floor Impact Questionnaire

POP:

Pelvic organ prolapse

POSST:

Pelvic Organ Support Study

PP:

Per-protocol

PVR:

Post-void residual

QoL:

Quality of life

UTI:

Urinary tract infection

References

  1. Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic level disorders successful US women. JAMA. 2008;300:1311–6. https://doi.org/10.1001/jama.300.11.1311.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Tegerstedt G, Maehle-Schmidt M, Nyrén O, Hammarström M. Prevalence of symptomatic pelvic organ prolapse successful a Swedish population. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16:497–503. https://doi.org/10.1007/s00192-005-1326-1.

    Article  PubMed  Google Scholar 

  3. Rortveit Guri MD, Brown JS, Thom DH, Van Den Eeden SK, Creasman JM, Subak LL. Symptomatic pelvic organ prolapse: prevalence and hazard factors successful a population-based, racially divers cohort. Obstet Gynecol. 2007;109:1396–403. https://doi.org/10.1097/01.AOG.0000263469.68106.

    Article  CAS  PubMed  Google Scholar 

  4. Barber MD, Maher C. Epidemiology and result appraisal of pelvic organ prolapse. Int Urogynecol J. 2013;24:1783–90. https://doi.org/10.1007/s00192-013-2169-9.

    Article  PubMed  Google Scholar 

  5. Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the prevalence of pelvic level disorders successful U.S. Women: 2010-2050. Obstet Gynecol. 2009;114:1278–83. https://doi.org/10.1097/AOG.0b013e3181c2ce96.

    Article  PubMed  Google Scholar 

  6. Gilchrist AS, Campbell W, Steele H, Brazell H, Foote J, Swift S. Outcomes of reflection arsenic therapy for pelvic organ prolapse: A survey successful the earthy past of pelvic organ prolapse. Neurourol Urodyn. 2013;32:383–6. https://doi.org/10.1002/nau.22298.

    Article  PubMed  Google Scholar 

  7. Atnip SD. Pessary usage and absorption for pelvic organ prolapse. Obstet Gynecol Clin N Am. 2009;36:541–63. https://doi.org/10.1016/j.ogc.2009.08.010.

    Article  Google Scholar 

  8. Turel Fatakia F, Pixton S, Caudwell Hall J, Dietz HP. Predictors of palmy ringing pessary usage successful women with pelvic organ prolapse. Aust N Z J Obstet Gynaecol. 2020;60:579–84. https://doi.org/10.1111/ajo.13152.

    Article  PubMed  Google Scholar 

  9. Swift S, Woodman P, O’boyle A, Kahn M, Valley M, Bland D, et al. Pelvic Organ Support Study (POSST): the distribution, objective definition, and epidemiologic information of pelvic organ enactment defects. Am J Obstet Gynecol. 2005;192:795–806. https://doi.org/10.1016/j.ajog.2004.10.602.

    Article  PubMed  Google Scholar 

  10. van der Vaart LR, Vollebregt A, Milani AL, Lagro-Janssen AL, Duijnhoven RG, Roovers JP, et al. Pessary oregon country for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study. BJOG. 2022;129:820–9. https://doi.org/10.1111/1471-0528.16950.

    Article  PubMed  Google Scholar 

  11. Robert M, Schulz JA, Harvey MA, Lovatsis D, Walter JE, Chou Q, Easton WA, et al. Technical update connected pessary use. J Obstet Gynaecol Can. 2013;35:664–74. https://doi.org/10.1016/S1701-2163(15)30888-4.

    Article  PubMed  Google Scholar 

  12. Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of pistillate pelvic organ prolapse and pelvic level dysfunction. Am J Obstet Gynecol. 1996;175:10–7. https://doi.org/10.1016/s0002-9378(96)70243-0.

    Article  CAS  PubMed  Google Scholar 

  13. Barber MD, Walters MD, Cundiff GW, PESSRI Trial Group. Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) successful women undergoing vaginal country and pessary attraction for pelvic organ prolapse. Am J Obstet Gynecol. 2006;194:1492–8. https://doi.org/10.1016/j.ajog.2006.01.076.

    Article  PubMed  Google Scholar 

  14. Harvey MA, Lemieux MC, Robert M, Schulz JA. Guideline No. 411: Vaginal Pessary Use. J Obstet Gynaecol Can. 2021;43(2):255–266.e1. Epub 2020 Nov 26. PMID: 33248302. https://doi.org/10.1016/j.jogc.2020.11.013.

    Article  PubMed  Google Scholar 

  15. de Albuquerque Coelho SC, Pereira GMV, Brito LGO, Juliato CRT. Cross sectional survey connected appraisal of ringing pessary cleaning and removal each six months: adverse events and complications. Int Urogynecol J. 2022;33:397–403. https://doi.org/10.1007/s00192-021-04775-1.

    Article  PubMed  Google Scholar 

  16. Hanson LAM, Schulz JA, Flood CG, Cooley B, Tam F. Vaginal pessaries successful managing women with pelvic organ prolapse and urinary incontinence: diligent characteristics and factors contributing to success. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17:155–9. https://doi.org/10.1007/s00192-005-1362-x.

    Article  CAS  PubMed  Google Scholar 

  17. Bai SW, Yoon BS, Kwon JY, Shin JS, Kim SK, Park KH. Survey of the characteristics and restitution grade of the patients utilizing a pessary. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16:182–6; treatment 186. https://doi.org/10.1007/s00192-004-1226-9.

    Article  PubMed  Google Scholar 

  18. Sarma S, Ying T, Moore KH. Long-term vaginal ringing pessary use: discontinuation rates and adverse events. BJOG. 2009;116:1715–21. https://doi.org/10.1111/j.1471-0528.2009.02380.x.

    Article  CAS  PubMed  Google Scholar 

  19. Dessie SG, Armstrong K, Modest AM, Hacker MR, Hota LS. Effect of vaginal estrogen connected pessary use. Int Urogynecol J. 2016;27:1423–9. https://doi.org/10.1007/s00192-016-3000-1.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Ramsay S, Tu le le M, Tannenbaum C. Natural past of pessary usage successful women aged 65-74 versus 75 years and older with pelvic organ prolapse: a 12-year study. Int Urogynecol J. 2016;27:1201–7. https://doi.org/10.1007/s00192-016-2970-3.

    Article  PubMed  Google Scholar 

  21. Fernando RJ, Sultan AH, Thakar R, Jeyanthan K. Management of the neglected vaginal ringing pessary. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:117–9. https://doi.org/10.1007/s00192-006-0089-7.

    Article  PubMed  Google Scholar 

  22. Miceli A, Fernández-Sánchez M, Dueñas-Díez JL. How often should ringing pessaries beryllium removed oregon changed successful women with precocious POP? A prospective observational study. Int Urogynecol J. 2021;32:1471–8. https://doi.org/10.1007/s00192-021-04706-0.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lone F, Thakar R, Sultan AH. One-year prospective examination of vaginal pessaries and country for pelvic organ prolapse utilizing the validated ICIQ-VS and ICIQ-UI (SF) questionnaires. Int Urogynecol J. 2015;26:1305–12. https://doi.org/10.1007/s00192-015-2686-9.

    Article  PubMed  Google Scholar 

  24. Gould FG, Carey MP, Plummer EL, Murray GL, Danielewski JA, Tabrizi SN. Garland SM Bacterial biofilm enactment connected vaginal ringing pessaries utilized for pelvic organ prolapse. Int Urogynecol J. 2022;33:287–95. https://doi.org/10.1007/s00192-021-04717-x.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors convey the investigators Dr. Joseph May (Ramat Hasharon, Israel) and Dr. Simon Dascalu (Hertzelia, Israel), who participated successful the study.

Additionally, the authors convey Dr. Lisa Deutsch for information absorption and statistical analyses and Enago (www.enago.jp) for editing this manuscript.

Funding

ConTIPI Medical Ltd. (Caesarea, Israel) funded this survey arsenic portion of its R&D/regulatory process. EZ, TS designed the survey and contributed arsenic employees and the probe team. However, the survey was conducted by an outer CRO, and statistical investigation was done by an outer firm. Therefore, the funder had nary engagement successful these activities. ConTIPI Medical Ltd. besides funded each costs related to this manuscript.

Author information

Authors and Affiliations

  1. ConTIPI Medical Ltd., 2 Alon Hatavor st., 3088900, Caesarea, Israel

    Elan Ziv & Tsvia Erlich

Contributions

EZ: Conceptualization, Methodology, Data postulation arsenic PI, Analysis of results, Writing - Original Draft. TS: Conceptualization, Methodology, Analysis of results, Writing - Original Draft. All authors person work and approved the last draught of the manuscript.

Corresponding author

Correspondence to Elan Ziv.

Ethics declarations

Ethics support and consent to participate

The survey was conducted successful enactment with the principles of the Declaration of Helsinki. Approval was granted by the institution’s morals committee (Assuta-Maccabi Helsinki committee, app #2014038).

Written and informed consent was obtained from each idiosyncratic participants included successful the study.

Consent for publication

Not applicable.

Competing interests

EZ has a struggle of involvement arsenic helium is an worker and shareholder astatine ConTIPI Medical who developed the studied device. EZ took portion successful the plan of the study, information collection, mentation of results and successful manuscript writing.

TS has a struggle of involvement arsenic she is simply a advisor and optionee astatine ConTIPI Medical who developed the studied device. TS took portion successful the plan of the study, mentation of results and successful manuscript writing.

Additional information

Publisher’s Note

Springer Nature remains neutral with respect to jurisdictional claims successful published maps and organization affiliations.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ziv, E., Erlich, T. Novel, disposable, self-inserted, vaginal instrumentality for the non-surgical absorption of pelvic organ prolapse: efficacy, safety, and prime of life. BMC Women's Health 22, 459 (2022). https://doi.org/10.1186/s12905-022-02057-6

Download citation

  • Received: 12 April 2022

  • Accepted: 03 November 2022

  • Published: 18 November 2022

  • DOI: https://doi.org/10.1186/s12905-022-02057-6

Keywords

  • Pelvic organ prolapse
  • Non-surgical management
  • Disposable vaginal device
  • Self-inserted device
Read Entire Article